Great Promising Researches !!
for the discovery that mature cells can be reprogrammed to become pluripotent.
Announcement of the 2012 Nobel Prize in Physiology or Medicine !!
UK, Japan scientists win Nobel for adult stem cell discovery
October 8th, 2012 John Gurdon, 79, of the Gurdon Institute in Cambridge, Britain and Shinya Yamanaka, 50, of Kyoto University in Japan, discovered ways to create tissue that would act like embryonic cells, without the need to collect the cells from embryos.
"My own personal belief is that we will, in the end, understand everything about how cells actually work ..."
Sir John B. Gurdon
#As far back as 1962 Gurdon became the first scientist to clone an animal, making a healthy tadpole from the egg of a frog with DNA from another tadpole's intestinal cell. That showed that developed cells carry the information to make every cell in the body - decades before other scientists made world headlines by cloning the first mammal from adult DNA, Dolly the sheep.
"My goal, all my life, is to bring this stem cell technology to the bedside, to patients, to clinics ..."
Shinya Yamanaka
# More than 40 years later, Yamanaka produced mouse stem cells from adult mouse skin cells by inserting a small number of genes. His breakthrough effectively showed that the development that takes place in adult tissue could be reversed, turning adult tissue back into cells that behave like embryos.
Front side (obverse) of the Nobel Prize Medal |
Scientists from Britain and Japan shared a Nobel Prize on Monday for the discovery that adult cells can be transformed back into embryo-like stem cells that may one day regrow tissue in damaged brains, hearts or other organs.
Shinya Yamanaka (right) and John B Gurdon (left), the winners of the 2012 Nobel prize in physiology or medicine. Photograph: Agencies |
Nobel prize in physiology or medicine 2012: as it happened
• John B Gurdon and Shinya Yamanaka have won the 2012 Nobel prize in physiology or medicine• Gurdon worked out that cells could be reprogrammed into a more immature state in 1962
• In 2006, Yamanaka worked out how to turn mature cells in mice into stem cells by introducing a few genes
• Yamanaka's 'induced pluripotent stem cells' removed the need to use live human embryos to create versatile stem cells
Transforming the field of "regenerative medicine":"These groundbreaking discoveries have completely changed our view of the development and specialization of cells," the Nobel Assembly at Stockholm's Karolinska Institute said.
Now:"We would like to be able to find a way of
obtaining spare heart or brain cells from skin or blood cells. The
important point is that the replacement cells need to be from the same
individual, to avoid problems of rejection and hence of the need for
immunosuppression."
And: 1. "You can't take out a large part of the heart or
the brain or so to study this, but now you can take a cell from, for
example, the skin of the patient, reprogramme it, return it to a
pluripotent state, and then grow it in a laboratory," he said
2. "The second thing is for further ahead. If you
can grow different cell types from a cell from a human, you might - in
theory for now but in future hopefully - be able to return cells where
cells have been lost."
3. Thomas Perlmann, Nobel Committee member and
professor of Molecular Development Biology at the Karolinska Institute
said: "Thanks to these two scientists, we know now that development is
not strictly a one-way street."
4. "There is lot of promise and excitement, and
difficult disorders such as neurodegenerative disorders, like perhaps
Alzheimer's and, more likely, Parkinson's disease, are very interesting
targets."
5. Asked why he still keeps his schoolteacher's
discouraging report, Gurdon said: "When you're having problems, like
when an experiment doesn't work - which often happens - it's nice to
remind yourself that perhaps after all you're not so good at this job
and the schoolmaster may have been right."
# Gurdon spoke of his own unlikely career as a
young man who loved science but was steered away from it at school, only
to take it up again at university.
He
still keeps an old school report in a frame on his desk: "I believe he
has ideas about becoming a scientist... This is quite ridiculous," his
teacher wrote. "It would be a sheer waste of time, both on his part and
of those who have to teach him."
Apprehensions: 1.The science of iPS cells is still in early
stages. Among concerns is the fear that implanted cells could grow out
of control and develop into tumors.
Stem cells created from adult tissue are known as "induced pluripotency stem cells", or iPS cells.
2. Some
scientists say stem cells from embryos may prove more useful against
disease than iPS cells, and the ethics of working with embryos should be
defended.
About:
Sir John B. Gurdon was born in 1933 in Dippenhall, UK. He received his Doctorate from the University of Oxford in 1960 and was a postdoctoral fellow at California Institute of Technology. He joined Cambridge University, UK, in 1972 and has served as Professor of Cell Biology and Master of Magdalene College. Gurdon is currently at the Gurdon Institute in Cambridge.
Shinya Yamanaka was born in Osaka, Japan in 1962. He obtained his MD in 1987 at Kobe University and trained as an orthopaedic surgeon before switching to basic research. Yamanaka received his PhD at Osaka City University in 1993, after which he worked at the Gladstone Institute in San Francisco and Nara Institute of Science and Technology in Japan. Yamanaka is currently Professor at Kyoto University and also affiliated with the Gladstone Institute.
Key publications: |
Gurdon, J.B. (1962). The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. Journal of Embryology and Experimental Morphology 10:622-640. |
Takahashi, K., Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. |
History of
The Nobel Prize in Physiology or Medicine
“The said interest shall be divided into five equal parts, which
shall be apportioned as follows: /- - -/ one part to the person who
shall have made the most important discovery within the domain of
physiology or medicine ...”
(Excerpt from the will of Alfred Nobel)
Alfred Nobel had an active interest in medical
research. Through Karolinska Institutet he came into contact with
Swedish physiologist Jöns Johansson around 1890. Johansson worked in
Nobel’s laboratory in Sevran, France for a time that year. Physiology or
medicine was the third prize area Nobel mentioned in his will.
In 1901, Emil von Behring was awarded the first Nobel
Prize in Physiology or Medicine for his work on serum therapy,
particularly for its use in the treatment of diphtheria. The Medicine
Prize has subsequently highlighted a number of important discoveries
including penicillin, genetic engineering and blood-typing.
The Nobel Prize in Physiology or Medicine is awarded by the Nobel Assembly at Karolinska Institutet, Stockholm, Sweden.
#The popular idea that a child forgets easily
is not an accurate one. Many people go right through life in the grip of
an idea which has been impressed on them in very tender years.
According to his Eton schoolmaster, the 15-year-old Gurdon did not stand out as a potential scientist. Writing in 2006,
Gurdon quoted a school report as saying: "I believe Gurdon has ideas
about becoming a scientist; on his present showing this is quite
ridiculous; if he can't learn simple biological facts, he would have no
chance of doing the work of a specialist, and it would be a sheer waste
of time, both on his part and of those who would have to teach him."
No comments:
Post a Comment